Pixium Vision S.A. buy krebskrebs
Start price
18.10.21
/
50%
€1.15
Target price
18.10.22
€2.00
Performance (%)
-89.39%
End price
19.10.22
€0.12
Summary
This prediction ended on 19.10.22 with a price of €0.12. The BUY prediction by krebskrebs for Pixium Vision S.A. performed very badly with a performance of -89.39%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Pixium Vision S.A. | - | - | - |
iShares Core DAX® | 1.851% | 5.158% | 17.711% |
iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% |
iShares Nikkei 225® | -0.412% | -2.857% | 13.501% |
iShares S&P 500 | 1.128% | 2.485% | 29.871% |
Comments by krebskrebs for this prediction
In the thread Pixium Vision S.A. diskutieren
Buy mit Kursziel 2,0
In the thread Trading Pixium Vision S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten